RxDoctor Payments Data

Edward Hahn, MD

Plastic and Reconstructive Surgery · Maywood, NJNPI 1356669162

Payments from drug & device makers

What this record shows

Integra Lifesciences Corporation accounts for 74.0% of it on its own, with 10 other manufacturers making up the rest.

$2,061in general payments, 2019–2025

Across 39 payments — averaging $52.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$2K
  • Kerecis Limited$131
  • Acera Surgical, Inc.$88
  • Endo Pharmaceuticals Inc.$61
  • Smith+Nephew$61
  • Musculoskeletal Transplant Foundation Inc.$47
  • plus $146 from 5 others

What the payments were for

  • Food & beverage$1,11054%
  • Other$95146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,061 in reported general payments places this provider in the 55th percentile of 93 plastic and reconstructive surgery providers in New Jersey.

See all plastic and reconstructive surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$35,762
Medicare patients
42
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin19$199
Cephalexin14$62
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$55
Tramadol Hcl18$54

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Maywood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →